Patiromer for high potassium in children under 12
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a medication called patiromer, which is a powder that helps lower high potassium levels in children under 12. It may be an option for children who have high potassium and can take medicine by mouth or through a feeding tube.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 12 years old throughout the first 28 days of the study.
- Your child must have high potassium levels (hyperkalemia) confirmed by two separate blood tests.
- Your child must be able to take food and medicine by mouth or through a feeding tube.
- If your child is on certain heart or blood pressure medications, those must be at a stable dose for at least 2 weeks before the study starts.
- Your child cannot be on regular hemodialysis (a machine that cleans the blood) or have had a kidney injury in the past 3 months.
- Your child should not have a severe stomach or bowel condition that could affect how the study drug moves through the body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if careful potassium management can help people with chronic kidney disease (CKD) safely take higher doses of blood pressure medicines called ACE inhibitors or ARBs, which are known to protect the kidneys. You may be eligible if you have moderate to advanced CKD and are already on a moderate dose of one of these medications.
This trial tests a new drug called WS016 to lower high potassium levels in adults. High potassium can be dangerous for your heart, and this study aims to find out if WS016 is safe and effective.
This study tests whether eating a higher-potassium diet is safe and helpful for people with early-to-moderate kidney failure who are not yet on dialysis. You may be asked to follow a specific diet plan and have blood tests to monitor potassium and other health markers.
This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.
This study tests a new medicine called finerenone (a pill) to see if it helps children with heart failure who have a weak pumping heart. It compares finerenone to a placebo (a pill with no medicine) while both groups continue their usual heart treatments.
This trial tests if a medication called patiromer, combined with a low-potassium diet, can help manage potassium levels in people on chronic dialysis. The goal is to improve quality of life by allowing a more flexible diet.
Hear when a new Hyperkalemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.